BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
36 results:

  • 1. colorectal cancer: Is it Still a Disease of the Elderly?
    Kędzia-Berut R; Berut M; Włodarczyk M; Włodarczyk J; Dziki Ł; Dziki A; Mik M
    Pol Przegl Chir; 2023 Dec; 96(0):41-45. PubMed ID: 38348978
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Initiating treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion.
    Khatib AW; Selub SM; Uryvaey A; Baranseh J; Shai A
    Chemotherapy; 2023; 68(2):95-101. PubMed ID: 36273438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Surgical treatment of digestive cancer in a well-defined elderly population.
    Latrille A; Bouvier AM; Jooste V; Bengrine Lefevre L; Quipourt V; Moreno Lopez N; Facy O
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101857. PubMed ID: 34963649
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.
    Pereira PL; Arnold D; de Baère T; Gomez F; Helmberger T; Iezzi R; Maleux G; Prenen H; Sangro B; Nordlund A; Zeka B; Bauer R; Kaufmann N; Pellerin O; Taieb J
    Dig Liver Dis; 2020 Aug; 52(8):857-861. PubMed ID: 32620520
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
    Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The clincopathological variables to differentiate the nature of isolated pulmonary nodules in patients who received curative surgery for colorectal cancer.
    Chang TK; Tsai HL; Su WC; Huang CW; Yeh YS; Ma CJ; Wang JY
    Asian J Surg; 2019 Feb; 42(2):425-432. PubMed ID: 30262438
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A cancer vaccine approach for personalized treatment of Lynch Syndrome.
    Majumder S; Shah R; Elias J; Manoharan M; Shah P; Kumari A; Chakraborty P; Kode V; Mistry Y; Coral K; Mittal B; Sm SM; Mahadevan L; Gupta R; Chaudhuri A; Khanna-Gupta A
    Sci Rep; 2018 Aug; 8(1):12122. PubMed ID: 30108227
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
    Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
    Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A Case of Synchronous Quadruple cancers Treated with Neoadjuvant Chemotherapy Followed by Surgery].
    Muramoto K; Miyake T; Shimizu T; Sonoda H; Ueki T; Terada Y; Mori H; Maehira H; Takebayashi K; Kaida S; Iida H; Yamaguchi T; Tani M
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1871-1873. PubMed ID: 29394804
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Cetuximab in association with an oxaliplatin-based chemotherapy as first-line treatment of metastatic colorectal cancer.].
    Petrelli F; Ghidini A; Zaniboni A
    Recenti Prog Med; 2017 Mar; 108(3):128-135. PubMed ID: 28398406
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
    Wilms D; Andrä J
    J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles.
    Rudzinski WE; Palacios A; Ahmed A; Lane MA; Aminabhavi TM
    Carbohydr Polym; 2016 Aug; 147():323-332. PubMed ID: 27178938
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Complementary value of pre-treatment apparent diffusion coefficient in rectal cancer for predicting tumor recurrence.
    Moon SJ; Cho SH; Kim GC; Kim WH; Kim HJ; Shin KM; Lee SM; Park JS; Choi GS; Kim SH
    Abdom Radiol (NY); 2016 Jul; 41(7):1237-44. PubMed ID: 26830420
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.
    Matthew EM; Zhou L; Yang Z; Dicker DT; Holder SL; Lim B; Harouaka R; Zheng SY; Drabick JJ; Lamparella NE; Truica CI; El-Deiry WS
    Oncotarget; 2016 Jan; 7(4):3662-76. PubMed ID: 26695546
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Recurrence patterns after resection of liver metastases from colorectal cancer.
    Sorbye H
    Recent Results Cancer Res; 2014; 203():243-52. PubMed ID: 25103010
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.
    Maletzki C; Klier U; Marinkovic S; Klar E; Andrä J; Linnebacher M
    Oncotarget; 2014 Jun; 5(12):4467-79. PubMed ID: 24962950
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide nk-2: the unique way of multi-drug resistance modulation.
    Banković J; Andrä J; Todorović N; Podolski-Renić A; Milošević Z; Miljković D; Krause J; Ruždijić S; Tanić N; Pešić M
    Exp Cell Res; 2013 Apr; 319(7):1013-27. PubMed ID: 23298945
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer.
    Shih YC; Elting LS; Pavluck AL; Stewart A; Halpern MT
    Cancer Invest; 2010 Jan; 28(1):46-53. PubMed ID: 19995227
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity.
    Negroni A; Stronati L; Grollino MG; Barattini P; Gumiero D; Danesi DT
    Int J Radiat Biol; 2008 Apr; 84(4):265-76. PubMed ID: 18386192
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
    Huguet EL; Old S; Praseedom RK; Balan KK; Gibbs P; Jamieson NV
    Hepatogastroenterology; 2007 Sep; 54(78):1667-71. PubMed ID: 18019690
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.